1. Gene Silencing Strategies in Cancer Therapy: An Update for Drug Resistance
   Sanaz Naghizadeh et al, 2019, Current Medicinal Chemistry CrossRef
2. Identification of MX2 as a Novel Prognostic Biomarker for Sunitinib Resistance in Clear Cell Renal Cell Carcinoma
   Yuang Wei et al, 2021, Frontiers in Genetics CrossRef
3. Targeting the PI3K/AKT signaling pathway in anticancer research: a recent update on inhibitor design and clinical trials (2020–2023)
   Dima A. Sabbah et al, 2024, Expert Opinion on Therapeutic Patents CrossRef
4. Potential role of genetic polymorphisms in neoadjuvant chemotherapy response in breast cancer
   Om Elez Bouhniz et al, 2024, Journal of Chemotherapy CrossRef
5. PI3K/AKT signaling pathway as a critical regulator of Cisplatin response in tumor cells
   ZAHRA NASRPOUR NAVAEI et al, 2021, Oncology Research CrossRef
6. MicroRNA-21 promotes phosphatase gene and protein kinase B/phosphatidylinositol 3-kinase expression in colorectal cancer
   Wei-Zhong Sheng et al, 2016, World Journal of Gastroenterology CrossRef
7. Noncoding RNAs in Drug Resistance of Gastrointestinal Stromal Tumor
   Jiehan Li et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
8. Knockdown ofAKT3(PKBγ) andPI3KCASuppresses Cell Viability and Proliferation and Induces the Apoptosis of Glioblastoma Multiforme T98G Cells
   Monika Paul-Samojedny et al, 2014, BioMed Research International CrossRef
9. Knockdown of PRDX2 sensitizes colon cancer cells to 5-FU by suppressing the PI3K/AKT signaling pathway
   Jun Xu et al, 2017, Bioscience Reports CrossRef
10. Computational modeling in melanoma for novel drug discovery
    Marzio Pennisi et al, 2016, Expert Opinion on Drug Discovery CrossRef